HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Richard C Becker Selected Research

Percutaneous Coronary Intervention

11/2022Biomarker-Based Prediction of Recurrent Ischemic Events in Patients With Acute Coronary Syndromes.
9/2019Direct factor IXa inhibition with the RNA-aptamer pegnivacogin reduces platelet reactivity in vitro and residual platelet aggregation in patients with acute coronary syndromes.
1/2016Use of Dual Antiplatelet Therapy and Patient Outcomes in Those Undergoing Percutaneous Coronary Intervention: The ROCKET AF Trial.
1/2016Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial.
6/2015Biomarkers for risk stratification of patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: Insights from the Platelet Inhibition and Patient Outcomes trial.
8/2014Use of the REG1 anticoagulation system in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the phase II RADAR-PCI study.
4/2014Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial.
4/2012Evaluation of dose requirements for prolonged bivalirudin administration in patients with renal insufficiency and suspected heparin-induced thrombocytopenia.
8/2011Factor IXa as a target for pharmacologic inhibition in acute coronary syndrome.
2/2011How Should Patients Requiring Dual Antiplatelet Therapy be Managed When Undergoing Elective Endoscopic Gastrointestinal Procedures?
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Richard C Becker Research Topics

Disease

103Hemorrhage
04/2024 - 07/2004
92Stroke (Strokes)
11/2022 - 11/2002
87Acute Coronary Syndrome
02/2024 - 05/2002
68Atrial Fibrillation
04/2024 - 02/2005
60Thrombosis (Thrombus)
04/2024 - 05/2002
55Myocardial Infarction
04/2024 - 09/2002
42Embolism (Embolus)
10/2021 - 11/2005
20Coronary Artery Disease (Coronary Atherosclerosis)
01/2023 - 09/2004
19Cardiovascular Diseases (Cardiovascular Disease)
04/2024 - 12/2004
14Heart Failure
12/2020 - 10/2004
12Thrombocytopenia (Thrombopenia)
01/2022 - 02/2005
11Inflammation (Inflammations)
04/2024 - 02/2003
11Myocardial Ischemia (Ischemic Heart Diseases)
02/2020 - 01/2008
6Ischemic Stroke
04/2024 - 12/2003
6Intracranial Hemorrhages (Intracranial Hemorrhage)
10/2021 - 09/2011
5Venous Thromboembolism
01/2020 - 07/2006
5Body Weight (Weight, Body)
01/2017 - 05/2002
5Hypersensitivity (Allergy)
12/2016 - 09/2004
5ST Elevation Myocardial Infarction
06/2015 - 02/2003
5Transient Ischemic Attack
05/2014 - 11/2005
5Coronary Disease (Coronary Heart Disease)
05/2013 - 05/2002
4Thromboembolism
01/2020 - 06/2008
4Anemia
04/2017 - 04/2006
4Chronic Renal Insufficiency
09/2013 - 09/2010
4Thrombophilia
11/2012 - 04/2006
3Vascular Diseases (Vascular Disease)
11/2022 - 10/2010
3COVID-19
01/2022 - 11/2021
3Neoplasms (Cancer)
12/2020 - 04/2006
3Atherosclerosis
01/2020 - 08/2004
3Obesity
12/2019 - 03/2010
3Peripheral Vascular Diseases (Peripheral Vascular Disease)
01/2019 - 12/2003
3Chronic Obstructive Pulmonary Disease (COPD)
06/2017 - 03/2014
3Atherosclerotic Plaque (Atheroma)
06/2015 - 05/2002
3Hemorrhagic Stroke
07/2014 - 10/2012
3Ischemia
12/2013 - 12/2009
3Renal Insufficiency (Renal Failure)
08/2013 - 09/2010
3Unstable Angina
10/2010 - 03/2004
3Heart Diseases (Heart Disease)
12/2009 - 01/2009
2Pulmonary Embolism
05/2023 - 07/2005

Drug/Important Bio-Agent (IBA)

58Warfarin (Coumadin)FDA LinkGeneric
07/2023 - 07/2005
48RivaroxabanIBA
10/2021 - 09/2011
47Clopidogrel (Plavix)FDA Link
11/2022 - 09/2004
42AnticoagulantsIBA
04/2024 - 05/2002
39TicagrelorIBA
11/2022 - 09/2009
35Vitamin KFDA Link
04/2024 - 06/2012
34Factor Xa (Coagulation Factor Xa)IBA
10/2021 - 05/2002
33Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
11/2023 - 05/2002
25Biomarkers (Surrogate Marker)IBA
02/2024 - 02/2005
24Heparin (Liquaemin)FDA LinkGeneric
04/2024 - 05/2002
11Factor Xa InhibitorsIBA
01/2020 - 05/2002
10Growth Differentiation Factor 15IBA
01/2023 - 01/2014
9CreatinineIBA
03/2016 - 09/2010
8Brain Natriuretic Peptide (Natrecor)FDA Link
01/2023 - 11/2012
8Glycoproteins (Glycoprotein)IBA
01/2019 - 08/2004
8EscitalopramFDA Link
01/2017 - 01/2012
7ThrombinFDA Link
04/2024 - 05/2002
7apixabanIBA
07/2023 - 06/2009
7pro-brain natriuretic peptide (1-76)IBA
01/2023 - 01/2014
7Proteins (Proteins, Gene)FDA Link
02/2020 - 07/2002
7RB 006IBA
09/2019 - 12/2009
7Enoxaparin (Lovenox)FDA LinkGeneric
02/2011 - 05/2002
6Troponin T (Troponin T1)IBA
01/2023 - 04/2016
6Cystatin CIBA
12/2019 - 01/2012
6Factor IXa (Coagulation Factor IXa)IBA
09/2019 - 06/2008
5Hemostatics (Antihemorrhagics)IBA
04/2024 - 04/2006
5C-Reactive ProteinIBA
01/2023 - 06/2005
5Purinergic P2Y Receptor AntagonistsIBA
06/2017 - 01/2009
5Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
08/2015 - 02/2005
5Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
02/2012 - 06/2008
5Peptide Hydrolases (Proteases)FDA Link
01/2012 - 06/2005
4vorapaxarIBA
11/2022 - 03/2009
4von Willebrand FactorIBA
11/2021 - 02/2012
4Adenosine Diphosphate (ADP)IBA
11/2016 - 03/2006
4AntithrombinsIBA
01/2014 - 02/2008
3Blood Coagulation Factors (Coagulation Factor)IBA
04/2024 - 01/2012
3LigandsIBA
01/2023 - 12/2014
3Thrombin Receptors (Thrombin Receptor)IBA
11/2022 - 10/2010
3VaccinesIBA
01/2022 - 04/2006
3bivalirudin (Angiomax)FDA Link
11/2021 - 04/2012
3Histones (Histone)IBA
02/2020 - 01/2014
3DNA (Deoxyribonucleic Acid)IBA
01/2020 - 01/2014
3Nucleotide AptamersIBA
09/2019 - 06/2008
3AntidotesIBA
01/2019 - 12/2006
3Tissue Plasminogen Activator (Alteplase)FDA Link
11/2017 - 12/2009
32'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
04/2017 - 01/2012
3StreptokinaseFDA Link
04/2017 - 07/2004
3RB 007IBA
01/2016 - 12/2009
3CollagenIBA
01/2014 - 11/2009
3Thromboplastin (Tissue Factor)IBA
01/2014 - 08/2004
3(2S)- 2- (4- (((3S)- 1- acetimidoyl- 3- pyrrolidinyl)oxy)phenyl)- 3- (7- amidino- 2- naphtyl)propanoic acidIBA
01/2006 - 05/2002
2Insulin (Novolin)FDA Link
06/2021 - 04/2006

Therapy/Procedure

70Therapeutics
04/2024 - 05/2002
20Percutaneous Coronary Intervention
11/2022 - 03/2006
15Stents
11/2021 - 02/2008
13Coronary Artery Bypass (Coronary Artery Bypass Surgery)
12/2018 - 03/2008
9Drug Therapy (Chemotherapy)
06/2021 - 06/2008
7Thrombolytic Therapy
11/2017 - 02/2003
5Catheters
12/2013 - 10/2009
5Secondary Prevention
11/2010 - 01/2008
3Prostheses and Implants (Prosthesis)
01/2020 - 12/2014